Omolin (Omeprazole)

Omeprazole, the active ingredient in Omolin, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omolin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omolin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omolin is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Erosive gastritis: promotes mucosal healing. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in chronic NSAID users. - Helicobacter pylori eradication regimens (adjunctive): enhances the effectiveness of antibiotic combinations.

Omolin may cause a range of adverse reactions. Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain or discomfort: mild cramps. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change. Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Osteoporotic fractures: increased risk with long‑term use. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions. - Liver enzyme elevation: abnormal hepatic function tests.

Before starting Omolin, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe renal impairment. - Review hepatic status: use with caution in moderate to severe liver disease. - Evaluate need for long‑term therapy: prolonged use is linked to bone density loss. - Monitor electrolytes: especially magnesium during extended treatment. - Pregnancy and lactation: weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omolin can interact with several medicines. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Dasatinib: lowered cancer‑drug exposure. Moderate Interactions (Monitor Closely): - Warfarin: potential INR elevation. - Phenytoin: altered seizure‑medication levels. - Methotrexate: increased systemic exposure. - Digoxin: modest increase in serum concentrations. - Vitamin D supplements: may affect calcium balance.